B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (37)
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
1991 • 2,447 citations
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
1992 • 1,573 citations
Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor Occupancy
1989 • 1,512 citations
The B7 and CD28 receptor families
1994 • 1,342 citations
The Role of the CD28 Receptor During T Cell Responses to Antigen
1993 • 1,320 citations
Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
1992 • 1,290 citations
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 • 1,154 citations
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
1992 • 1,076 citations
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
1994 • 838 citations
Dominance and Crypticity of T Cell Antigenic Determinants
1993 • 838 citations
Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
1985 • 734 citations
Treatment of Murine Lupus with CTLA4Ig
1994 • 683 citations
Depletion of CD4 + T Cells in Major Histocompatibility Complex Class II-Deficient Mice
1991 • 673 citations
Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.
1993 • 569 citations
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
1994 • 482 citations
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
1995 • 387 citations
Costimulation of T cells for tumor immunity
1993 • 324 citations
CD28-B7 interactions in T-cell activation
1994 • 315 citations
Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.
1993 • 274 citations
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53
1993 • 267 citations
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection
1995 • 225 citations
Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules
1995 • 225 citations
Domain interactions of H–2 class I antigens alter cytotoxic T-cell recognition sites
1984 • 207 citations
Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
1994 • 145 citations
Tumor Antigens
1992 • 138 citations
Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb‐restricted ovalbumin peptide and an assessment of the predictive power of MHC‐binding motifs
1992 • 134 citations
Tumor immunotherapy: the tumor cell as an antigen-presenting cell
1994 • 132 citations
Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16.
1992 • 129 citations
Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes.
1992 • 128 citations
Peptide loading of empty major histocompatibility complex molecules on RMA‐S cells allows the induction of primary cytotoxic T lymphocyte responses
1991 • 94 citations
Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious?
1995 • 81 citations
In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation.
1995 • 70 citations
Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells.
1977 • 32 citations
A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
1994 • 30 citations
Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes.
1992 • 23 citations
Production of Interleukin-2 by EL4 Tumor Cells Induces Natural Killer Cell- and T-Cell-Mediated Immunity
1994 • 15 citations
Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes
1993 • 15 citations
Cited By (0)
No citing papers found in database